ArticleBioinformatics advances2025
Sequali: efficient and comprehensive quality control of short- and long-read sequencing data.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Whole-genome sequencing with AVITI and NovaSeq X Plus reveals comparable performance with contextual biases.NAR genomics and bioinformatics · 2026Article
- Methodological Comparison of Short-Read and Long-Read Sequencing Methods on Colorectal Cancer Samples.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Quality control of sequencing data is the first step in many sequencing workflows. Short- and long-read sequencing technologies have many commonalities with regard to quality control. Several quality control programs exist; however, none possess a feature set that is adequate for both technologies. Quality control programs aimed at Oxford Nanopore Technologies sequencing lack vital features, such as adapter searching, overrepresented sequence analysis, and duplication analysis. Results: Sequali was developed to provide sequencing quality control for both short- and long-read sequencing technologies. It features adapter search, overrepresented sequence analysis, and duplication analysis and supports FASTQ and uBAM inputs. It is significantly faster than comparable sequencing quality control programs for both short- and long-read sequencing technologies. Availability and Implementation: Sequali is an open-source Python application using C extensions and is freely available under the AGPL-3.0 license at https://github.com/rhpvorderman/sequali. The source code for each release is archived at zenodo: https://zenodo.org/doi/10.5281/zenodo.10822485.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.